Search

Your search keyword '"Sialoglycoproteins deficiency"' showing total 110 results

Search Constraints

Start Over You searched for: Descriptor "Sialoglycoproteins deficiency" Remove constraint Descriptor: "Sialoglycoproteins deficiency"
110 results on '"Sialoglycoproteins deficiency"'

Search Results

1. DSPP dosage affects tooth development and dentin mineralization.

2. Dentin Sialophosphoprotein Deletion Leads to Femoral Head Cartilage Attenuation and Subchondral Bone Ill-mineralization.

3. Ultrastructural organization of dentin in mice lacking dentin sialo-phosphoprotein.

4. Coordinated and unique functions of the E-selectin ligand ESL-1 during inflammatory and hematopoietic recruitment in mice.

5. Dentin sialophosphoprotein (DSPP) plays an essential role in the postnatal development and maintenance of mouse mandibular condylar cartilage.

6. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.

7. Haploinsufficiency of E-selectin ligand-1 is associated with reduced atherosclerotic plaque macrophage content while complete deficiency leads to early embryonic lethality in mice.

8. Deletion of densin-180 results in abnormal behaviors associated with mental illness and reduces mGluR5 and DISC1 in the postsynaptic density fraction.

9. Epicutaneous challenge of orally immunized mice redirects antigen-specific gut-homing T cells to the skin.

10. Diminished thrombogenic responses by deletion of the Podocalyxin Gene in mouse megakaryocytes.

11. Dentin sialophosphoprotein in biomineralization.

12. Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation.

13. Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing.

14. Absence of bone sialoprotein (BSP) impairs cortical defect repair in mouse long bone.

15. Osteopontin is associated with nuclear factor kappaB gene expression during tail-suspension-induced bone loss.

16. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death.

17. Osteopontin deficiency protects mice from Dextran sodium sulfate-induced colitis.

18. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.

19. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells.

20. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.

21. [NASH model-- role of interleukin-1 receptor].

22. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice.

23. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice.

24. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway.

25. Osteopontin participates in Th1-mediated host resistance against nonlethal malaria parasite Plasmodium chabaudi chabaudi infection in mice.

26. Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice.

27. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.

28. The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis.

29. Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure.

30. T-bet-dependent expression of osteopontin contributes to T cell polarization.

31. Involvement of tumor necrosis factor-alpha in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice.

32. Osteopontin and related SIBLING glycoprotein genes are expressed by Sertoli cells during mouse testis development.

33. CD43 is required for optimal growth inhibition of Mycobacterium tuberculosis in macrophages and in mice.

34. Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor.

35. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size.

36. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro.

37. Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin.

38. Exacerbation of granuloma formation in IL-1 receptor antagonist-deficient mice with impaired dendritic cell maturation associated with Th2 cytokine production.

39. Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice.

40. Deficiency in systemic interleukin-1 receptor antagonist production as an operative risk factor in malnourished elderly patients with colorectal carcinoma.

41. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases.

42. Osteopontin-deficiency suppresses growth of B16 melanoma cells implanted in bone and osteoclastogenesis in co-cultures.

43. Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium.

44. Altered vascular remodeling in osteopontin-deficient atherosclerotic mice.

45. Profibrotic effects of angiotensin II in the heart: a matter of mediators.

46. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.

47. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.

48. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.

49. CD43 regulation of T cell activation is not through steric inhibition of T cell-APC interactions but through an intracellular mechanism.

50. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.

Catalog

Books, media, physical & digital resources